Choice International Limited (BOM:531358)
India · Delayed Price · Currency is INR 740.85
+1.05 (0.14%)
At close: Aug 8, 2025
Marinus Pharmaceuticals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Interest and Dividend Income | - | - | 1,464 | 809.5 | 618.44 | 282.91 | Upgrade |
Total Interest Expense | 740.48 | 660.87 | 366.6 | 200.09 | 141.94 | 141.29 | Upgrade |
Net Interest Income | -740.48 | -660.87 | 1,097 | 609.41 | 476.51 | 141.62 | Upgrade |
Trading & Principal Transactions | - | - | 11.01 | 25.8 | 79.03 | - | Upgrade |
Gain on Sale of Investments (Rev) | - | - | 3.66 | 0.27 | 0.86 | 6.51 | Upgrade |
Other Revenue | 9,537 | 9,217 | 6,110 | 3,107 | 2,155 | 1,381 | Upgrade |
| 8,796 | 8,556 | 7,222 | 3,743 | 2,711 | 1,530 | Upgrade | |
Revenue Growth (YoY) | 12.89% | 18.46% | 92.97% | 38.04% | 77.27% | 43.77% | Upgrade |
Salaries & Employee Benefits | 2,760 | 2,740 | 2,211 | 1,090 | 569.5 | 419.38 | Upgrade |
Cost of Services Provided | 3,532 | 3,518 | 303.19 | 141.07 | 90.01 | 798.38 | Upgrade |
Other Operating Expenses | - | - | 2,791 | 1,570 | 1,267 | 21.74 | Upgrade |
Total Operating Expenses | 6,389 | 6,343 | 5,376 | 2,853 | 1,964 | 1,290 | Upgrade |
Operating Income | 2,408 | 2,213 | 1,847 | 889.42 | 747.18 | 239.21 | Upgrade |
Other Non-Operating Income (Expenses) | - | - | -34.65 | -14.25 | -10.26 | -10.64 | Upgrade |
EBT Excluding Unusual Items | 2,408 | 2,213 | 1,812 | 875.17 | 736.92 | 228.57 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | -4.28 | -55.69 | -0.56 | - | Upgrade |
Pretax Income | 2,408 | 2,213 | 1,808 | 819.52 | 736.36 | 228.16 | Upgrade |
Income Tax Expense | 621.2 | 585.83 | 499.38 | 218.84 | 200.31 | 61.06 | Upgrade |
Earnings From Continuing Ops. | 1,787 | 1,627 | 1,309 | 600.68 | 536.05 | 167.1 | Upgrade |
Minority Interest in Earnings | - | - | - | - | -0.28 | - | Upgrade |
Net Income | 1,787 | 1,627 | 1,309 | 600.68 | 535.76 | 167.1 | Upgrade |
Net Income to Common | 1,787 | 1,627 | 1,309 | 600.68 | 535.76 | 167.1 | Upgrade |
Net Income Growth | 26.17% | 24.34% | 117.85% | 12.12% | 220.62% | 34.42% | Upgrade |
Shares Outstanding (Basic) | 200 | 199 | 199 | 199 | 177 | 86 | Upgrade |
Shares Outstanding (Diluted) | 205 | 204 | 201 | 199 | 177 | 131 | Upgrade |
Shares Change (YoY) | 1.83% | 1.53% | 0.57% | 12.42% | 35.61% | 54.09% | Upgrade |
EPS (Basic) | 8.93 | 8.16 | 6.57 | 3.02 | 3.02 | 1.95 | Upgrade |
EPS (Diluted) | 8.73 | 7.99 | 6.52 | 3.01 | 3.02 | 1.28 | Upgrade |
EPS Growth | 23.90% | 22.55% | 116.61% | -0.33% | 136.40% | -12.80% | Upgrade |
Free Cash Flow | - | -3,243 | -1,611 | 1,121 | -376.91 | -460.03 | Upgrade |
Free Cash Flow Per Share | - | -15.92 | -8.03 | 5.62 | -2.13 | -3.52 | Upgrade |
Operating Margin | 27.37% | 25.86% | 25.57% | 23.76% | 27.56% | 15.64% | Upgrade |
Profit Margin | 20.31% | 19.02% | 18.12% | 16.05% | 19.76% | 10.93% | Upgrade |
Free Cash Flow Margin | - | -37.90% | -22.31% | 29.96% | -13.90% | -30.08% | Upgrade |
Effective Tax Rate | 25.80% | 26.47% | 27.62% | 26.70% | 27.20% | 26.76% | Upgrade |
Revenue as Reported | 9,537 | 9,217 | 7,593 | 3,952 | 2,860 | 1,758 | Upgrade |
Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.